Foghorn Therapeutics, Inc. (FHTX)
5.73
-0.10
(-1.72%)
USD |
NASDAQ |
Feb 20, 16:00
5.73
0.00 (0.00%)
After-Hours: 18:42
Foghorn Therapeutics EPS Diluted (Quarterly) : -0.2514 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Halozyme Therapeutics, Inc. | -1.203 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fortress Biotech, Inc. | 0.111 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.85M |
| Revenue (Quarterly) | 8.153M |
| Total Expenses (Quarterly) | 24.00M |
| Enterprise Value | 182.53M |
| Gross Profit Margin (Quarterly) | 88.96% |
| Profit Margin (Quarterly) | -194.4% |
| Earnings Yield | -20.71% |
| Normalized Earnings Yield | -20.71 |